BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29396598)

  • 1. Genomic Alterations in Sporadic Pituitary Tumors.
    Bi WL; Larsen AG; Dunn IF
    Curr Neurol Neurosci Rep; 2018 Feb; 18(1):4. PubMed ID: 29396598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond.
    Shen AJJ; King J; Scott H; Colman P; Yates CJ
    Expert Rev Endocrinol Metab; 2019 Nov; 14(6):399-418. PubMed ID: 31793361
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
    Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
    Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
    Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
    J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Genetic Causes of Pituitary Adenomas.
    Caimari F; Korbonits M
    Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.
    Oikonomou E; Barreto DC; Soares B; De Marco L; Buchfelder M; Adams EF
    J Neurooncol; 2005 Jul; 73(3):205-9. PubMed ID: 15980970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease.
    Weigand I; Knobloch L; Flitsch J; Saeger W; Monoranu CM; Höfner K; Herterich S; Rotermund R; Ronchi CL; Buchfelder M; Glatzel M; Hagel C; Fassnacht M; Deutschbein T; Sbiera S
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2535-2546. PubMed ID: 30844069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.
    Bi WL; Greenwald NF; Ramkissoon SH; Abedalthagafi M; Coy SM; Ligon KL; Mei Y; MacConaill L; Ducar M; Min L; Santagata S; Kaiser UB; Beroukhim R; Laws ER; Dunn IF
    Endocrinology; 2017 Jul; 158(7):2284-2291. PubMed ID: 28486603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
    Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel
    Uzilov AV; Cheesman KC; Fink MY; Newman LC; Pandya C; Lalazar Y; Hefti M; Fowkes M; Deikus G; Lau CY; Moe AS; Kinoshita Y; Kasai Y; Zweig M; Gupta A; Starcevic D; Mahajan M; Schadt EE; Post KD; Donovan MJ; Sebra R; Chen R; Geer EB
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001602. PubMed ID: 28487882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
    Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M
    Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas.
    Losa M; Mortini P; Pagnano A; Detomas M; Cassarino MF; Pecori Giraldi F
    Endocrine; 2019 Feb; 63(2):240-246. PubMed ID: 30315484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
    Asa SL; Mete O; Ezzat S
    Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report.
    Bao XD; Lu L; Zhu HJ; Yao Y; Feng M; Wang RZ; Zhai X; Fu Y; Gong FY; Lu ZL
    BMC Endocr Disord; 2022 Jun; 22(1):152. PubMed ID: 35668434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
    Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
    Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
    Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
    Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.
    Brastianos PK; Taylor-Weiner A; Manley PE; Jones RT; Dias-Santagata D; Thorner AR; Lawrence MS; Rodriguez FJ; Bernardo LA; Schubert L; Sunkavalli A; Shillingford N; Calicchio ML; Lidov HG; Taha H; Martinez-Lage M; Santi M; Storm PB; Lee JY; Palmer JN; Adappa ND; Scott RM; Dunn IF; Laws ER; Stewart C; Ligon KL; Hoang MP; Van Hummelen P; Hahn WC; Louis DN; Resnick AC; Kieran MW; Getz G; Santagata S
    Nat Genet; 2014 Feb; 46(2):161-5. PubMed ID: 24413733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status.
    Bujko M; Kober P; Boresowicz J; Rusetska N; Paziewska A; Dąbrowska M; Piaścik A; Pękul M; Zieliński G; Kunicki J; Bonicki W; Ostrowski J; Siedlecki JA; Maksymowicz M
    Eur J Endocrinol; 2019 Dec; 181(6):615-627. PubMed ID: 31581124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
    Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
    Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.